FDA grants Breakthrough status for Alzheimer's treatment
/PRNewswire/ -- Renew Bioscience, a commercial stage medical technology company, announced it has received Breakthrough Device Designation status from the U.S....
Stay updated with breaking news from Device Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Renew Bioscience, a commercial stage medical technology company, announced it has received Breakthrough Device Designation status from the U.S....
Press release content from PR Newswire. The AP news staff was not involved in its creation.
/PRNewswire/ -- Renew Bioscience, a commercial stage medical technology company, announced it has received Breakthrough Device Designation status from the U.S....
Varian announces that the US Food and Drug Administration (FDA) has granted the company Breakthrough Device Designation for its Embozene microspheres for genicular artery embolization (GAE) for symptomatic knee osteoarthritis.
/PRNewswire/ -- Varian, a Siemens Healthineers company, announced today that the U.S. Food and Drug Administration (FDA) has granted the company Breakthrough...